
Drug Discovery and Development
Technology In Transition
- 1st Edition - November 24, 2005
- Imprint: Churchill Livingstone
- Author: Humphrey P. Rang
- Language: English
HIGHLY COMMENDED IN THE MEDICINE CATEGORY IN THE BMA 2006 MEDICAL BOOK COMPETITION!Winner of the Royal Society of Medicine Library Prize for Medical Book of the Year!Of the initia… Read more
Purchase options

HIGHLY COMMENDED IN THE MEDICINE CATEGORY IN THE BMA 2006 MEDICAL BOOK COMPETITION!
Winner of the Royal Society of Medicine Library Prize for Medical Book of the Year!
Of the initial thousands of compounds with initial promise of drugs only a small handful be developed for human clinical trials and perhaps only one will become an approved drug. This book describes the huge complexities involved in bringing a drug to market and how new molecular understanding and techniques can make the process more targeted and successful.
Winner of the Royal Society of Medicine Library Prize for Medical Book of the Year!
Of the initial thousands of compounds with initial promise of drugs only a small handful be developed for human clinical trials and perhaps only one will become an approved drug. This book describes the huge complexities involved in bringing a drug to market and how new molecular understanding and techniques can make the process more targeted and successful.
- Includes the new molecular techniques of drug design and development.
- Discusses current therapeutic needs.
- Covers pharmacoepidemiology and pharmacoeconomics.
- Edited by Humphrey Rang, who is also known throughout the world as a co-author of the enormously successful and authoritative textbook, Pharmacology, now in its fifth edition.
- Foreword by Daniel Vasella, CEO, Novartis International.
- Includes contributors from both the pharmaceutical industry and universities.
Those working in or aspiring to work in the pharmaceutical industry
Students of pharmaceutical medicine
Pharmacy and pharmacology department libraries
Students of pharmaceutical medicine
Pharmacy and pharmacology department libraries
Section 1: Introduction:
Development of the pharmaceutical industry
Nature of disease and the purpose of therapy
Therapeutic modalities
Section 2: Drug discovery
The drug discovery process:
General principles and some case histories
Choosing the project
Choosing the target
The role of genomics and bioinformatics
High throughput screening
The role of chemistry in the drug discovery process
Pharmacokinetic issues in drug discovery
Pharmacology: its role in drug discovery
Biopharmaceuticals
Patent issues in drug discovery
Organisation of a large drug discovery department
Section 3: Drug development:
Introduction
Assessing drug safety
Pharmaceutical development
Clinical development
Protecting the assets: patenting and intellectual property
Regulatory affairs
Marketing the drug
Section 4: Facts and figures:
Drug discovery and development: Facts and figures
Development of the pharmaceutical industry
Nature of disease and the purpose of therapy
Therapeutic modalities
Section 2: Drug discovery
The drug discovery process:
General principles and some case histories
Choosing the project
Choosing the target
The role of genomics and bioinformatics
High throughput screening
The role of chemistry in the drug discovery process
Pharmacokinetic issues in drug discovery
Pharmacology: its role in drug discovery
Biopharmaceuticals
Patent issues in drug discovery
Organisation of a large drug discovery department
Section 3: Drug development:
Introduction
Assessing drug safety
Pharmaceutical development
Clinical development
Protecting the assets: patenting and intellectual property
Regulatory affairs
Marketing the drug
Section 4: Facts and figures:
Drug discovery and development: Facts and figures
- Edition: 1
- Published: November 24, 2005
- Imprint: Churchill Livingstone
- Language: English
HR
Humphrey P. Rang
Affiliations and expertise
Emeritus Professor of Pharmacology, University College London, London, UK